Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. 1993

A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0724.

Protease nexin-2/amyloid beta protein precursor (PN-2/A beta PP) is an abundant, secreted platelet protein which is a potent inhibitor of coagulation Factor XIa. We examined other potential anticoagulant activities of PN-2/A beta PP. Purified Kunitz protease inhibitor domain of PN-2/A beta PP and PN-2/A beta PP itself were found to prolong the coagulation time of plasma and pure Factor IXa. The Kunitz protease inhibitor domain also inhibited the ability of Factor IXa to activate Factor X. PN-2/A beta PP inhibited Factor IXa with a Ki of 7.9 to 3.9 x 10(-11) M in the absence and presence of heparin, respectively. When the second-order rate constant of PN-2/A beta PP's inhibition of Factor IXa (2.7 x 10(8) M-1min-1) was compared to that of antithrombin III (3.8 x 10(6) M-1min-1), PN-2/A beta PP was at least a 71-fold more potent inhibitor of Factor IXa than antithrombin III. PN-2/A beta PP formed a complex with Factor IXa as detected by gel filtration and ELISA. The finding that PN-2/A beta PP is a potent inhibitor of Factor IXa could help to explain the spontaneous intracerebral hemorrhages seen in patients with hereditary cerebral hemorrhage with amyloidosis Dutch-type where there is an extensive accumulation of PN-2/A beta PP in their cerebral blood vessels.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D015949 Factor IXa Activated form of factor IX. This activation can take place via the intrinsic pathway of blood coagulation by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X. Coagulation Factor IXa,Factor IX, Activated,Blood Coagulation Factor IX, Activated,Factor 9A,Factor Nine A,Activated Factor IX,Factor IXa, Coagulation
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid

Related Publications

A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
June 2000, Biochemistry,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
November 1993, The Journal of clinical investigation,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
December 2005, Proceedings of the National Academy of Sciences of the United States of America,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
April 1995, Thrombosis research,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
June 1990, The Journal of biological chemistry,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
October 1995, The Journal of biological chemistry,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
August 2000, Thrombosis research,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
February 1991, Biochemical and biophysical research communications,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
December 1992, Annals of the New York Academy of Sciences,
A H Schmaier, and L D Dahl, and A J Rozemuller, and R A Roos, and S L Wagner, and R Chung, and W E Van Nostrand
May 1990, Science (New York, N.Y.),
Copied contents to your clipboard!